Patents
Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
11/2007
11/08/2007CA2647766A1 A convergent process for the synthesis of taxane derivatives
11/07/2007EP1664033B1 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
11/07/2007CN101066924A 2-hexyl-3-hydroxy-5-R1-oxy hexadecyl carboxylic R2 ester and its prepn and use in preparing orlistat as slimming medicine
10/2007
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007CN101062925A Paclitaxel derivatives, preparation method and medicinal composition and usage thereof
10/30/2007US7288665 Process for selective derivatization of taxanes
10/30/2007US7288664 Reverse Kleiner method for manufacturing nitrogen dioxide, nitric oxide, nitric acid, metallic ascorbates and alkyl ascorbates of vitamin C
10/25/2007US20070249849 reacting aldehyde with organic halide in carbon chain extension reaction to form alcohol compound comprising functional group capable of allowing for carbonylation of said alcohol compound, then reacting alcohol compound in carbonylation reaction to form hydroxycarboxylic acid, then cyclizing
10/25/2007US20070249708 C7 ester and c10 hydroxy substituted taxanes
10/25/2007US20070249707 Taxanes having c7 hydroxy and c10 heterosubstituted acetate substituents
10/16/2007US7282597 Ascorbic acid derivatives and skin-whitening cosmetics
10/16/2007US7282590 Drug conjugates
10/11/2007WO2007112570A1 Thermal extraction method and product
10/11/2007CA2647564A1 Thermal extraction method and product
10/10/2007EP1842849A1 Trisoxetane compound, process for producing the same, and optical waveguide using the same
10/10/2007CN101050207A Trisoxetane compound, process for producing the same, and optical waveguide using the same
10/10/2007CN100341863C Epoxidation process
10/10/2007CN100341853C Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound
10/09/2007US7279586 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
10/04/2007WO2007111390A1 Stationary phase and column using cucurbituril bonded silica gel, and separation method of taxol using the column
10/03/2007CN101048395A Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
10/03/2007CN101048394A Semi-synthetic conversion of paclitaxel to docetaxel
10/03/2007CN101045719A Method for high efficiency separating and purifying 1-deacetyl Baccatins III (10-DABIII)
10/03/2007CN101045718A Method for separating and purifying 10-deacetyl Baccatins III
10/02/2007US7276499 Sulfur-containing taxanes, specially covalently bonded to a cell binding agent for targeted delivey to specific cell populations
09/2007
09/27/2007WO2007109654A2 Docetaxel polymorphs and processes
09/27/2007US20070225510 Convergent Process for the Synthesis of Taxane Derivatives
09/26/2007CN100339373C Paclitaxel analogs, preparation and use as antitumor agents
09/20/2007US20070218531 Micro-Organism and a Method of Producing Paclitaxel by the Use of the Same
09/19/2007CN100338049C Process for the preparation of the 14beta-hydroxy-baccatin III-1, 14-carbonate
09/18/2007CA2415097C Process and intermediate compounds for the preparation of pyrrolidines
09/13/2007WO2007101335A1 Conversion 9-dihydro-13-acetylbaccatin iii to 10-deacetylbaccatin iii
09/13/2007US20070213393 Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
09/12/2007CN101035778A Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
09/12/2007CN101033218A Method of extracting Paclitaxel and 9-dihydro-13-acetyl baccatin III from taxus genus
09/12/2007CN101033217A Conversion 9-dihydro-13-acetylbaccatin iii to 10-deacetylbaccatin iii
09/08/2007CA2538860A1 Conversion 9-dihydro-13-acetylbaccatin iii to 10-deacetylbaccatin iii
09/07/2007WO2007099669A1 Dioxetane compound, cationically polymerizable composition, optical film and liquid crystal display unit
09/06/2007US20070208185 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
09/06/2007US20070208183 Hydrogenation process for the conversion of a carboxylic acid or an ester having a carbonyl group
09/05/2007CN101029049A Use of recovered and reutilized quinine derivative derivative ligand in synthesizing paclitaxel and polyene paclitaxel sided chain
09/05/2007CN101029034A Polyenic taxol soluble derivative, its preparation and use
09/04/2007US7265231 3-methyl oxetanemethanol derivatives and their use in perfume compositions
08/2007
08/30/2007WO2007079444A3 Preparation of alkyl ketene dimers
08/30/2007US20070203334 Process for preparing a synthetic intermediate for preparation of branched nucleosides
08/29/2007EP1826198A1 Method for the synthesis of the sodium salt of retinoyl-cysteic acid and retinoyl-cysteine sulfinic acid
08/23/2007WO2007094173A1 Adamantane derivative, composition comprising the derivative, and optical and electronic member using the composition
08/23/2007WO2007073937A3 Process for preparing crystalline forms of orlistat
08/23/2007US20070197775 Cytotoxic agents comprising taxanes and their therapeutic use
08/23/2007US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use
08/22/2007EP1819688A2 Crystalline forms of docetaxel and processes for their preparation
08/22/2007EP1819687A2 Cytotoxic agents comprising new c-2 modified taxanes
08/22/2007CN101020676A Semi-synthesis process of taxol and docetaxel
08/22/2007CN101020675A Semi-synthesis process of taxol and docetaxel
08/22/2007CN101020674A Synthesis process of taxol and docetaxel with new side chain and their derivatives
08/22/2007CN101020673A Semi-synthesis process of taxol and docetaxel
08/22/2007CN101020672A Process of synthesizing docetaxel
08/22/2007CN101020671A Process of separating and purifying taxol efficiently
08/21/2007US7259268 Method for purification of paclitaxel from paclitaxel-containing materials
08/16/2007WO2007075825A3 Lipophilic anticancer drug compounds
08/16/2007WO2006135656B1 Processes for the preparation of paclitaxel
08/16/2007US20070191617 Process for producing 2,2,3,3-tetrafluorooxetane
08/16/2007US20070191598 Process for Preparing Gemcitabine and Associated Intermediates
08/16/2007US20070190623 Process for purification and recovery of paclitaxel compounds
08/15/2007EP1818328A1 Chromatographic method for the isolation and purification of taxane derivatives
08/15/2007CN1331859C Separation method of taxinol from cephalotaxin
08/15/2007CN101016282A Preparing method of C7, C10 substituted 1-dehydroxy baccatin VI derivative
08/14/2007US7256299 light-emitting dioxetanes; cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection
08/14/2007US7256213 Taxanes having a C10 carbonate substituent
08/08/2007EP1814868A1 Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
08/08/2007EP0706376B2 Anti-angiogenic compositions and methods of use
08/08/2007CN101012210A Taxone derivatives, preparing method and pharmaceutical use thereof
08/08/2007CN101011576A Compositions and methods for treating or preventing inflammatory diseases
08/07/2007CA2470124C Process for preparing 10-desacetylbaccatine iii
08/01/2007CN101007795A Paclitaxel and docetaxel synthesis method
08/01/2007CN101007173A Anti-angiogene compositions and methods of use
07/2007
07/25/2007EP1810968A2 9, 10-a, a-OH-texane analogs and methods for production thereof
07/25/2007EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/25/2007CN1328269C Process for preparing taxol
07/24/2007US7247738 Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
07/23/2007CA2533414A1 Semi-synthetic route for the preparation of paclitaxel ocetaxel and 10-deacetylbaccatin iii from 9-dihydro-13-acetylbaccatin iii
07/19/2007US20070167637 Catalytic nuclear hydrogenation of 4,4'-bis[(3-ethyloxetan-3-yl)methoxymethyl]biphenylto 4,4'-bis[(3-ethyloxetan-3-yl)methoxymethyl]bicyclohexyl; photoinitiators; ultravioletradiation; cationic polymerization; coatings; adhesives; electronis; dentistry; heat resistance; toughness; shrinkage inhibition
07/18/2007CN100998869A Anti-angiogene compositions and methods of use
07/18/2007CN100998565A Anti-angiogene compositions and methods of use
07/17/2007US7244798 E.g., 2-[p-(p-[p-(3-ethyl-3-oxetanylmethoxy)benzoyl]phenoxycarbonyl)phenoxy]ethyl acrylate; excellent in reactivity upon fixation of the liquid crystal orientation structure
07/17/2007US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
07/12/2007WO2007079444A2 Preparation of alkyl ketene dimers
07/12/2007WO2007078050A2 Method for preparation of amorphous, anhydrous crystalline, or hydrated crystalline docetaxel
07/12/2007WO2006113432A3 Compounds, compositions and methods
07/12/2007US20070161806 Catalyst for the carbonylation of oxiraines
07/12/2007CA2636083A1 Preparation of alkyl ketene dimers
07/11/2007EP1428823B1 Liquid-crystalline oxetane compound, polymerizable liquid-crystalline composition, process for producing liquid-crystal film, optical film, and liquid-crystal display
07/11/2007CN1997634A Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
07/10/2007USRE39723 Semi-synthetic taxanes with antitumor and antiangiogenetic activities
07/10/2007US7241907 Acetone solvate of dimethoxy docetaxel and its process of preparation
07/05/2007WO2007075825A2 Lipophilic anticancer drug compounds
07/05/2007WO2007051632A3 Surfactant precursor
07/05/2007US20070155972 Method for separating trioxane from a mixture containing trioxane, formaldehyde and water
07/05/2007US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
07/04/2007EP1803714A1 Process for preparing crystalline forms of orlistat
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 55